BRIEF-Sanofi Genzyme says Saskatchewan has added Lemtrada to province's MS drugs program

Tue Jul 5, 2016 8:10am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

July 5 (Reuters) - Sanofi Sa

* Saskatchewan has added Lemtrada to province's MS drugs program for eligible people living with relapsing-remitting multiple sclerosis Source text for Eikon: Further company coverage: )